文献速递免疫规划传染病防控与疫情报告

靶向MHC II类分子的无针DNA疫苗保护恒河猴抵抗H1N1流感

Needle-free delivery of DNA: Targeting of hemagglutinin to MHC class II molecules protects rhesus macaques against H1N1 influenza.
PubMed 文献 · Vaccine · 2019-01-09

研究将流感血凝素靶向Mamu II类分子的双价融合蛋白DNA疫苗,经无针喷射皮内注射免疫恒河猴,诱导中和抗体和抗原特异性T细胞,未观察到不良反应,免疫猴在流感病毒攻击后获得保护。

要点

  • DNA疫苗经无针喷射皮内注射可诱导恒河猴中和抗体与T细胞应答
  • 靶向MHC II类分子策略在非人灵长类中增强DNA疫苗免疫原性
  • 免疫恒河猴在流感病毒攻击后获得保护且无不良反应

核心结论

  • 编码靶向Mamu II类分子双价融合蛋白的DNA疫苗经无针喷射皮内免疫可保护恒河猴抵抗H1N1流感病毒攻击。

研究设计与样本

  • 研究用编码双价融合蛋白的DNA疫苗免疫非人灵长类恒河猴,该融合蛋白将流感病毒血凝素靶向Mamu II类分子。
  • DNA通过无痛无针喷射注射方式皮内递送。

主要发现

  • 免疫诱导了中和抗体和抗原特异性T细胞。
  • 未观察到不良反应。
  • 免疫恒河猴在流感病毒攻击后获得保护。

临床怎么用

  • 提示靶向MHC II类分子的DNA疫苗经无针皮内递送可作为流感大流行时快速覆盖的候选策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Conventional influenza vaccines are hampered by slow and limited production capabilities, whereas DNA vaccines can be rapidly produced for global coverage in the event of an emerging pandemic. However, a drawback of DNA vaccines is their generally low immunogenicity in non-human primates and humans. We have previously demonstrated that targeting of influenza hemagglutinin to human HLA class II molecules can increase antibody responses in larger animals such as ferrets and pigs. Here, we extend these observations by immunizing non-human primates (rhesus macaques) with a DNA vaccine encoding a bivalent fusion protein that targets influenza virus hemagglutinin (HA) to Mamu class II molecules. Such immunization induced neutralizing antibodies and antigen-specific T cells. The DNA was delivered by pain- and needle-free jet injections intradermally. No adverse effects were observed. Most importantly, the immunized rhesus macaques were protected against a challenge with influenza virus.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Mooij P, Grødeland G, Koopman G, et al. Needle-free delivery of DNA: Targeting of hemagglutinin to MHC class II molecules protects rhesus macaques against H1N1 influenza. Vaccine. 2019. PMID: 30638800. doi:10.1016/j.vaccine.2018.12.049

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。